EMVERM chewable tablets one step closer to market for treatment of pinworm
by Press Release from Outbreak News Today on (#10XGB)
Impax Laboratories, Inc. announced this week that the United States Food and Drug Administration (FDA) has approved the Company's supplemental new drug application (sNDA) for EMVERM (mebendazole) 100 mg chewable tablets. EMVERM is indicated for the treatment of Enterobius vermicularis (pinworm), Trichuris trichiura (whipworm), Ascaris lumbricoides (common roundworm), Ancylostoma duodenale (common hookworm), Necator americanus (American ["]
